H.Res.286 - Expressing the sense of the House of Representatives on promoting initiatives to develop an HIV vaccine.109th Congress (2005-2006)
ResolutionHide Overview icon-hide
|Sponsor:||Rep. Visclosky, Peter J. [D-IN-1] (Introduced 05/18/2005)|
|Committees:||House - International Relations|
|Latest Action:||05/18/2005 Referred to the House Committee on International Relations. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.Res.286 — 109th Congress (2005-2006)All Information (Except Text)
Introduced in House (05/18/2005)
Expresses the sense of the House that the President should: (1) mobilize necessary economic and scientific support for the Global HIV Vaccine Enterprise (an alliance of the world's leading scientists and independent organizations committed to accelerating the development of an HIV vaccine by enhancing coordination, information sharing, and collaboration globally); and (2) urge members of the Group of Eight (Canada, France, Germany, Italy, Japan, Russia, the United Kingdom, and the United States) to garner support from their own communities for the development of an HIV vaccine.
Calls for such countries to: (1) take further measures to explore and implement Enterprise initiatives; (2) leverage financial contributions from the international philanthropic community to provide funding to promote the development of an HIV vaccine; (3) include the scientific and political leadership of the countries most affected by the pandemic of HIV and AIDS; and (4) develop a plan for furthering such efforts prior to their June 2005 meeting.
Urges the President to generate global support for the Global HIV Vaccine Enterprise by carrying out an initiative that: (1) coordinates and partners with member countries, the private sector, and other countries; (2) encourages Group of Eight countries to act swiftly to mobilize resources; (3) includes a strategic plan to prioritize challenges to the development of an HIV vaccine, to coordinate research and product development, and to encourage greater use of information-sharing networks and technologies; (4) encourages the establishment of coordinated global HIV vaccine development centers; and (5) increases cooperation and communication among regulatory agencies on issues related to AIDS and HIV.